5-Amino-1MQ in Thailand: NNMT Inhibitor & Metabolic Therapy
5-Amino-1MQ is a selective NNMT inhibitor that raises intracellular NAD+ availability to enhance fat oxidation, support healthy body composition, and improve cellular energy metabolism. In physician-supervised protocols, it is used for metabolic optimization and weight management support.
Doctor-prescribed 5-Amino-1MQ in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified oral capsules. It is typically prescribed in protocols targeting fat oxidation, body composition improvement, and cellular NAD+ replenishment.
How 5-Amino-1MQ Works
5-Amino-1MQ operates through sophisticated pathways to optimize metabolic function. Its primary mechanism involves inhibiting nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular energy metabolism. This inhibition leads to enhanced NAD+ availability and improved metabolic efficiency. The compound also demonstrates significant effects on fat metabolism and energy production through multiple molecular pathways.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
5-Amino-1MQ
Category
Oral Peptide
Dosage
50mg per capsule
Frequency
3 capsules daily (150mg total)
Administration
Oral capsules
Potential Benefits
- · Supports metabolic health
- · Enhances energy production
- · Promotes fat metabolism
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
5-Amino-1MQ requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Supports metabolic health
Enhances energy production
Promotes fat metabolism
Supports weight management
Improves cellular energy
Enhances exercise performance
Supports healthy aging
Optimizes body composition
Increases vitality
Supports metabolic flexibility
Speak with a physician
Interested in 5-Amino-1MQ?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
50mg per capsule
Frequency
3 capsules daily (150mg total)
Duration
8-12 weeks
Administration
Oral capsules
Safety guide
5-Amino-1MQ Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent 5-Amino-1MQ Research
Nicotinamide N-methyltransferase Inhibition Improves Cardiac Function in a Heart Failure Model
Demonstrated 5A1MQ (NNMT inhibitor) improved cardiac function and structure in HFpEF models by restoring NAD+ metabolism and reducing metabolic dysfunction (Pharmacol Res, 2025).
View on PubMedNicotinamide N-methyltransferase Inhibition Mitigates Obesity-related Metabolic Dysfunction
Showed 5A1MQ treatment reduced body weight, improved insulin sensitivity, and decreased fat mass in obese mice by inhibiting NNMT and restoring NAD+ availability (Diabetes Obes Metab, 2024).
View on PubMedReduced Calorie Diet Combined with NNMT Inhibition Establishes a Distinct Microbiome in Obese Mice
Demonstrated that combining 5-amino-1-methylquinolinium (5A1MQ) with caloric restriction produced superior metabolic outcomes and favourable gut microbiome changes compared to diet alone (Sci Rep, 2022).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about 5-Amino-1MQ